# CorneaGen, Inc. – FDA Inspection, Jun 17, 2013

Source: https://www.keypedia.com/records/fda_inspections/corneagen-inc/70266549-6fb8-4dad-a3eb-91b42632b947
Source feed: FDA_Inspections

> FDA inspection 836377 of CorneaGen, Inc., June 17, 2013. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 836377
- Company Name: CorneaGen, Inc.
- Inspection Date: 2013-06-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1282090 - 2025-09-10
- [FDA Inspection 1176014 - 2022-07-29](https://www.keypedia.com/records/fda_inspections/corneagen-inc/0201d817-ccbe-4bb1-9e8f-206c099898f3)
- FDA Inspection 1047476 - 2018-02-27
- [FDA Inspection 977565 - 2016-06-15](https://www.keypedia.com/records/fda_inspections/corneagen-inc/134fd718-00a2-40fe-82d3-32a116632cc5)

Company: https://www.keypedia.com/companies/corneagen-inc/57206953-05f1-4b04-8917-be34f14885c3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d